| Dr Juan Carlos Brenes, MD | |
|
1150 N 35th Ave Ste 605, Hollywood, FL 33021-5431 | |
| (954) 265-7900 | |
| (954) 276-0271 |
| Full Name | Dr Juan Carlos Brenes |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 25 Years |
| Location | 1150 N 35th Ave Ste 605, Hollywood, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013118405 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | ME96350 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Regional Hospital | Hollywood, FL | Hospital |
| Memorial Hospital West | Pembroke pines, FL | Hospital |
| Memorial Hospital Miramar | Miramar, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Broward Hospital District | 8123927373 | 534 |
| Hollywood Medical Center Ekg Associates Pa | 8628052891 | 38 |
| Memorial Ekg Associates Pa | 9931183191 | 43 |
News Archive
To address the current reactive approaches to treating chronic and post-acute care conditions, SAP AG is launching a new solution. The SAP® Collaborative E-Care Management application connects patients, care providers and their families through medical monitoring software and mobile devices to better manage their health with individualized treatment plans and educational content.
In a study of community-dwelling Medicare beneficiaries aged 65 and older who were asked about sleep disturbances, 56% were estimated to be at high risk of obstructive sleep apnea, but only 8% of the high-risk individuals had been tested for it. Of those tested, 94% were diagnosed with obstructive sleep apnea.
La Jolla Institute for Allergy & Immunology scientists have identified the histamine releasing factor (HRF) molecule as a promising target for developing new treatments for a number of allergic reactions including asthma.
Pharmacyclics, Inc announced today updated results from three trials of Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), for the treatment of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
The United States Department of Health and Human Services is encouraging Americans to learn about their families' health histories as a way of promoting personal health and preventing disease.
› Verified 6 days ago
| Entity Name | Memorial Ekg Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063625754 PECOS PAC ID: 9931183191 Enrollment ID: O20040615001364 |
News Archive
To address the current reactive approaches to treating chronic and post-acute care conditions, SAP AG is launching a new solution. The SAP® Collaborative E-Care Management application connects patients, care providers and their families through medical monitoring software and mobile devices to better manage their health with individualized treatment plans and educational content.
In a study of community-dwelling Medicare beneficiaries aged 65 and older who were asked about sleep disturbances, 56% were estimated to be at high risk of obstructive sleep apnea, but only 8% of the high-risk individuals had been tested for it. Of those tested, 94% were diagnosed with obstructive sleep apnea.
La Jolla Institute for Allergy & Immunology scientists have identified the histamine releasing factor (HRF) molecule as a promising target for developing new treatments for a number of allergic reactions including asthma.
Pharmacyclics, Inc announced today updated results from three trials of Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), for the treatment of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
The United States Department of Health and Human Services is encouraging Americans to learn about their families' health histories as a way of promoting personal health and preventing disease.
› Verified 6 days ago
| Entity Name | Hollywood Medical Center Ekg Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124127378 PECOS PAC ID: 8628052891 Enrollment ID: O20040615001404 |
News Archive
To address the current reactive approaches to treating chronic and post-acute care conditions, SAP AG is launching a new solution. The SAP® Collaborative E-Care Management application connects patients, care providers and their families through medical monitoring software and mobile devices to better manage their health with individualized treatment plans and educational content.
In a study of community-dwelling Medicare beneficiaries aged 65 and older who were asked about sleep disturbances, 56% were estimated to be at high risk of obstructive sleep apnea, but only 8% of the high-risk individuals had been tested for it. Of those tested, 94% were diagnosed with obstructive sleep apnea.
La Jolla Institute for Allergy & Immunology scientists have identified the histamine releasing factor (HRF) molecule as a promising target for developing new treatments for a number of allergic reactions including asthma.
Pharmacyclics, Inc announced today updated results from three trials of Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), for the treatment of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
The United States Department of Health and Human Services is encouraging Americans to learn about their families' health histories as a way of promoting personal health and preventing disease.
› Verified 6 days ago
| Entity Name | Mount Sinai Medical Center Cardiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134366727 PECOS PAC ID: 6800953118 Enrollment ID: O20090331000260 |
News Archive
To address the current reactive approaches to treating chronic and post-acute care conditions, SAP AG is launching a new solution. The SAP® Collaborative E-Care Management application connects patients, care providers and their families through medical monitoring software and mobile devices to better manage their health with individualized treatment plans and educational content.
In a study of community-dwelling Medicare beneficiaries aged 65 and older who were asked about sleep disturbances, 56% were estimated to be at high risk of obstructive sleep apnea, but only 8% of the high-risk individuals had been tested for it. Of those tested, 94% were diagnosed with obstructive sleep apnea.
La Jolla Institute for Allergy & Immunology scientists have identified the histamine releasing factor (HRF) molecule as a promising target for developing new treatments for a number of allergic reactions including asthma.
Pharmacyclics, Inc announced today updated results from three trials of Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), for the treatment of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
The United States Department of Health and Human Services is encouraging Americans to learn about their families' health histories as a way of promoting personal health and preventing disease.
› Verified 6 days ago
| Entity Name | South Broward Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326479585 PECOS PAC ID: 8123927373 Enrollment ID: O20140319001324 |
News Archive
To address the current reactive approaches to treating chronic and post-acute care conditions, SAP AG is launching a new solution. The SAP® Collaborative E-Care Management application connects patients, care providers and their families through medical monitoring software and mobile devices to better manage their health with individualized treatment plans and educational content.
In a study of community-dwelling Medicare beneficiaries aged 65 and older who were asked about sleep disturbances, 56% were estimated to be at high risk of obstructive sleep apnea, but only 8% of the high-risk individuals had been tested for it. Of those tested, 94% were diagnosed with obstructive sleep apnea.
La Jolla Institute for Allergy & Immunology scientists have identified the histamine releasing factor (HRF) molecule as a promising target for developing new treatments for a number of allergic reactions including asthma.
Pharmacyclics, Inc announced today updated results from three trials of Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), for the treatment of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
The United States Department of Health and Human Services is encouraging Americans to learn about their families' health histories as a way of promoting personal health and preventing disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Juan Carlos Brenes, MD 2900 Corporate Way, Door D, Miramar, FL 33025-3925 Ph: (954) 276-5685 | Dr Juan Carlos Brenes, MD 1150 N 35th Ave Ste 605, Hollywood, FL 33021-5431 Ph: (954) 265-7900 |
News Archive
To address the current reactive approaches to treating chronic and post-acute care conditions, SAP AG is launching a new solution. The SAP® Collaborative E-Care Management application connects patients, care providers and their families through medical monitoring software and mobile devices to better manage their health with individualized treatment plans and educational content.
In a study of community-dwelling Medicare beneficiaries aged 65 and older who were asked about sleep disturbances, 56% were estimated to be at high risk of obstructive sleep apnea, but only 8% of the high-risk individuals had been tested for it. Of those tested, 94% were diagnosed with obstructive sleep apnea.
La Jolla Institute for Allergy & Immunology scientists have identified the histamine releasing factor (HRF) molecule as a promising target for developing new treatments for a number of allergic reactions including asthma.
Pharmacyclics, Inc announced today updated results from three trials of Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), for the treatment of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
The United States Department of Health and Human Services is encouraging Americans to learn about their families' health histories as a way of promoting personal health and preventing disease.
› Verified 6 days ago
Dr. David Lee Arnold, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1701 Fletcher St, Hollywood, FL 33020 Phone: 208-841-4552 | |
Dr. Hugo Victor Bejar, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 795 S Federal Hwy, Hollywood, FL 33020 Phone: 954-923-4646 | |
Dr. Wayne Brett Schonfeld, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 4700 Sheridan St, Suite F, Hollywood, FL 33021 Phone: 954-961-8400 Fax: 954-963-8508 | |
Michael S Marek, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3702 Washington St, Suite 303, Hollywood, FL 33021 Phone: 954-967-6550 Fax: 954-967-6553 | |
Larrye Michael Feldman, DO Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3389 Sheridan St, Box #204, Hollywood, FL 33021 Phone: 954-240-0813 | |
Lawrence Michael Reiss, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1150 N 35th Ave, Suite 605, Hollywood, FL 33021 Phone: 954-265-7900 Fax: 954-276-0264 |